China Digest: Innoforce nets $96m Series A; Winicssec bags $46m Series D

Innoforce Pharmaceuticals has raised 625 million yuan ($96 million) in a Series A round of financing, while Winicssec has garnered 300 million yuan ($46 million) in a Series D round of funding led by China’s state-owned Capital Venture Investment Fund.